104 related articles for article (PubMed ID: 26160816)
1. [Association between Multiple Sclerosis or Neuromyelitis Optica and Epstein-Barr Virus].
Mori M
Brain Nerve; 2015 Jul; 67(7):881-90. PubMed ID: 26160816
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications.
Bjornevik K; Münz C; Cohen JI; Ascherio A
Nat Rev Neurol; 2023 Mar; 19(3):160-171. PubMed ID: 36759741
[TBL] [Abstract][Full Text] [Related]
3. The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis.
Wunsch M; Hohmann C; Milles B; Rostermund C; Lehmann PV; Schroeter M; Bayas A; Ulzheimer J; Mäurer M; Ergün S; Kuerten S
Viruses; 2016 Apr; 8(4):105. PubMed ID: 27120609
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus and Human Endogenous Retrovirus in Japanese Patients with Autoimmune Demyelinating Disorders.
Cossu D; Tomizawa Y; Sechi LA; Hattori N
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138980
[TBL] [Abstract][Full Text] [Related]
5. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis.
Ziaei A; Solomon O; Casper TC; Waltz M; Weinstock-Guttman B; Aaen G; Wheeler Y; Graves J; Benson L; Gorman M; Rensel M; Mar S; Lotze T; Greenberg B; Chitnis T; Waldman AT; Krupp L; James JA; Hart J; Barcellos LF; Waubant E
Mult Scler; 2024 Mar; 30(3):308-315. PubMed ID: 38332747
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors.
Jacobs BM; Giovannoni G; Cuzick J; Dobson R
Mult Scler; 2020 Oct; 26(11):1281-1297. PubMed ID: 32202208
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and Epstein-Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection.
Rousseau BA; Bhaduri-McIntosh S
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112929
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein-Antibody-Associated Disease.
Fadda G; Yea C; O'Mahony J; Waters P; Yeh EA; Marrie RA; Arnold D; Bar-Or A; Banwell B;
Ann Neurol; 2024 Apr; 95(4):700-705. PubMed ID: 38411340
[TBL] [Abstract][Full Text] [Related]
9. EBV and MS: The evidence is growing stronger.
Farrell PJ
Cell; 2023 Dec; 186(26):5675-5676. PubMed ID: 38134873
[TBL] [Abstract][Full Text] [Related]
10. Risk of multiple sclerosis in individuals with infectious mononucleosis: a national population-based cohort study using hospital records in England, 2003-2023.
Goldacre R
Mult Scler; 2024 Apr; 30(4-5):489-495. PubMed ID: 38511730
[TBL] [Abstract][Full Text] [Related]
11. EBV infection drives MS pathology: No.
't Hart BA; van Luijn MM
Mult Scler; 2024 Apr; 30(4-5):485-487. PubMed ID: 38602258
[No Abstract] [Full Text] [Related]
12. EBV-specific T cells in multiple sclerosis.
Wood H
Nat Rev Neurol; 2024 May; 20(5):255. PubMed ID: 38594556
[No Abstract] [Full Text] [Related]
13. EBV infection drives MS pathology: Yes.
Aloisi F; Salvetti M
Mult Scler; 2024 Apr; 30(4-5):483-485. PubMed ID: 38602260
[No Abstract] [Full Text] [Related]
14. EBV infection drives MS pathology: Commentary.
Cortese M; Ascherio A
Mult Scler; 2024 Apr; 30(4-5):487-488. PubMed ID: 38602259
[No Abstract] [Full Text] [Related]
15. Adverse Childhood Experiences and the Risk of Multiple Sclerosis Development: A Review of Potential Mechanisms.
Eid K; Bjørk MH; Gilhus NE; Torkildsen Ø
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338799
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy with tenofovir in MS.
Torkildsen Ø; Myhr KM; Brugger-Synnes P; Bjørnevik K
Mult Scler Relat Disord; 2024 Mar; 83():105436. PubMed ID: 38217968
[TBL] [Abstract][Full Text] [Related]
17. [Genetic variability in the association of multiple sclerosis and Epstein-Barr virus].
Rivera-Silva G
Rev Med Inst Mex Seguro Soc; 2022 Jul; 60(4):361-362. PubMed ID: 35816619
[TBL] [Abstract][Full Text] [Related]
18. Editorial: Epstein-Barr Virus and multiple sclerosis.
Houen G; Ruprecht K
Front Immunol; 2023; 14():1330181. PubMed ID: 38250064
[No Abstract] [Full Text] [Related]
19. The pathogenesis of multiple sclerosis: a series of unfortunate events.
van Noort JM; Baker D; Kipp M; Amor S
Clin Exp Immunol; 2023 Dec; 214(1):1-17. PubMed ID: 37410892
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in understanding the pathogenesis and biological treatment of multiple sclerosis.
Buc M
Bratisl Lek Listy; 2023; 124(12):903-906. PubMed ID: 37983285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
